EPISTEME PROGNOSTICS
Episteme Prognostics is a precision medicine company that develops therapeutic biomarkers for pancreatic cancer. It predicts chemotherapy response and assesses the benefit of epigenetic therapy to pancreatic cancer patients. Episteme Prognostics was co-founded by Dr. Steven Leach and Surajit Dhara.
EPISTEME PROGNOSTICS
Industry:
Biotechnology Health Care Health Diagnostics Medical Therapeutics
Founded:
2019-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.epistemedx.com
Status:
Active
Email Addresses:
[email protected]
Similar Organizations
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Medostic
Medostic is a digital therapeutics company that develops closed-loop systems for critical care.
Pacylex
Pacylex Pharmaceuticals develops a precision medicine solution for multiple common cancers.
Slive
Slive focuses on medical platform development for detecting biomarkers from saliva.
Founder
Official Site Inspections
http://www.epistemedx.com
- Host name: 198.49.23.145
- IP address: 198.49.23.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
